Sedana Medical AB (publ) (STO:SEDANA)

Market Cap	857.28M -53.3%
Revenue (ttm)	200.23M +12.0%
Net Income	-59.24M
EPS	-0.60
Shares Out	99.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,544
Average Volume	196,170
Open	8.68
Previous Close	8.79
Day's Range	8.52 - 8.69
52-Week Range	6.65 - 18.94
Beta	0.97
RSI	33.42
Earnings Date	Feb 12, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 122
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.